NO962549L - Reptidinhibitorer av CXC interkrine molekyler - Google Patents

Reptidinhibitorer av CXC interkrine molekyler

Info

Publication number
NO962549L
NO962549L NO962549A NO962549A NO962549L NO 962549 L NO962549 L NO 962549L NO 962549 A NO962549 A NO 962549A NO 962549 A NO962549 A NO 962549A NO 962549 L NO962549 L NO 962549L
Authority
NO
Norway
Prior art keywords
reptide
inhibitors
molecules
cxc intercrine
cxc
Prior art date
Application number
NO962549A
Other languages
English (en)
Other versions
NO962549D0 (no
Inventor
Allen Barry Cohen
Edmund J Miller
Shinichiro Hayashi
Anna K Kurdowska
Ronald R Tuttle
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of NO962549D0 publication Critical patent/NO962549D0/no
Publication of NO962549L publication Critical patent/NO962549L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NO962549A 1993-12-15 1996-06-14 Reptidinhibitorer av CXC interkrine molekyler NO962549L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1993/012245 WO1995016702A1 (en) 1993-12-15 1993-12-15 Peptide inhibitors of cxc intercrine molecules

Publications (2)

Publication Number Publication Date
NO962549D0 NO962549D0 (no) 1996-06-14
NO962549L true NO962549L (no) 1996-08-14

Family

ID=22237305

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962549A NO962549L (no) 1993-12-15 1996-06-14 Reptidinhibitorer av CXC interkrine molekyler

Country Status (7)

Country Link
EP (1) EP0734394A1 (no)
JP (1) JPH09510688A (no)
KR (1) KR100290224B1 (no)
AU (1) AU685079B2 (no)
FI (1) FI962413A (no)
NO (1) NO962549L (no)
WO (1) WO1995016702A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110889A (en) * 1996-06-14 2000-08-29 Board Of Regents, The University Of Texas System Peptide tumor cell growth inhibitors
JP4704317B2 (ja) * 1996-12-26 2011-06-15 株式会社日本触媒 樹脂粒子の製造方法
CN103524602B (zh) * 2013-10-30 2015-04-08 重庆市畜牧科学院 抗菌肽在制药中的应用
CA3112169A1 (en) * 2018-09-11 2020-03-19 Anbition S.R.L. Peptides and medical uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0497867A1 (en) * 1989-10-23 1992-08-12 Schering Corporation Polypeptide inhibitors of gamma interferon
US5079228A (en) * 1990-02-05 1992-01-07 Board Of Regents, The University Of Texas System Peptide inhibitors of neutrophil activating factor induced chemotaxis
WO1992009300A1 (en) * 1990-11-21 1992-06-11 Iterex Pharmaceuticals Ltd. Partnership Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures

Also Published As

Publication number Publication date
AU685079B2 (en) 1998-01-15
NO962549D0 (no) 1996-06-14
KR960706503A (ko) 1996-12-09
JPH09510688A (ja) 1997-10-28
FI962413A (fi) 1996-07-24
KR100290224B1 (ko) 2001-05-15
AU6014794A (en) 1995-07-03
EP0734394A1 (en) 1996-10-02
FI962413A0 (fi) 1996-06-11
WO1995016702A1 (en) 1995-06-22

Similar Documents

Publication Publication Date Title
ATE222240T1 (de) Hiv - protease inhibitoren
NO942064D0 (no) yminhibitorer
DE69612575D1 (de) Hocheffiziente Übersetzung von mRNA Molukülen
EE9700093A (et) Apolipoproteiin-B sünteesi inhiibitorid
MX9100998A (es) Novedosos inhibidores de escualen sintetasa
DE69328166D1 (de) Beseitigung von schmutzstoffen
FI962097A0 (fi) Menetelmä kovien puuelementtien valmistamiseksi
DE69307470D1 (de) Polymerablagerungsinhibitor
DE69414032T2 (de) Hochfrequenzverstärker
NO962549L (no) Reptidinhibitorer av CXC interkrine molekyler
FI941146A (fi) Iskulaite
DE69314762D1 (de) Polymerablagerungsinhibitor
DE59405917D1 (de) Epoxy-derivate von polyacrylamiden
DE69306168D1 (de) Polymerablagerungsinhibitor
DE69303055D1 (de) Polymerbelagerungsinhibitor
DE69417915D1 (de) Reinigung von uranhexafluorid
NO953272L (no) Kombinasjoner av retrovirale inhibitorer
ITMI930345A1 (it) N-acil-peptidi inibitori delle protein-chinasi
KR950004679U (ko) 광디스크기기의 방전장치
NO303110B1 (no) Anordning for innretting av virkeselement
KR950012506U (ko) 변성기의 고정 클램프
KR950011773U (ko) 신경제 기둥보의 형틀
KR950009273U (ko) 구조부재류의 고정클립
KR950003784U (ko) 투포원 연사기의 드럼
KR960031416U (ko) 투포원연사기의 스핀들

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application